Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,694 | -89,625 | -63,466 | -39,697 | -19,210 |
| Depreciation Amortization | 958 | 604 | 128 | -122 | -110 |
| Other Working Capital | -3,856 | 6,384 | 2,751 | -442 | -3,655 |
| Other Operating Activity | 5,075 | 12,807 | 9,065 | 5,705 | 3,153 |
| Operating Cash Flow | $-28,517 | $-69,830 | $-51,522 | $-34,556 | $-19,822 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -186,189 | -97,765 | -37,850 | 7,005 | 27,972 |
| PPE Investments | -31 | -2,171 | -1,896 | -1,231 | -511 |
| Investing Cash Flow | $-186,220 | $-99,936 | $-39,746 | $5,774 | $27,461 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -750 | -250 | 0 | 0 | 0 |
| Common Stock Issued | 829 | 469,584 | 142,298 | 137,615 | 247 |
| Financing Cash Flow | $79 | $469,334 | $142,298 | $137,615 | $247 |
| Beginning Cash Position | 325,703 | 26,135 | 26,135 | 26,135 | 26,135 |
| End Cash Position | 111,045 | 325,703 | 77,165 | 134,968 | 34,021 |
| Net Cash Flow | $-214,658 | $299,568 | $51,030 | $108,833 | $7,886 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,517 | -69,830 | -51,522 | -34,556 | -19,822 |
| Capital Expenditure | -31 | -2,171 | -1,896 | -1,231 | -511 |
| Free Cash Flow | -28,548 | -72,001 | -53,418 | -35,787 | -20,333 |